Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06930807Not ApplicableRecruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
Adaptive TreatmentMinimal Residual DiseaseNon-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2025-03-25

Research Network

Collaboration Network

18 collaborators·53 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

China National Institute for Occupational Safety and Health (NIOSH/CDC)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ziming Li, MD

Shanghai Chest Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungAdaptive TreatmentNeoplasm, Residual

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Kezhong Chen, MD

Peking University People's Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungAdaptive TreatmentNeoplasm, Residual

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Jun Yin, MD

Shanghai Zhongshan Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Rong Yin, MD

Jiangsu Cancer Institute & Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Yuan Cheng, MD

Peking University First Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Zizi Zhou, MD

Shenzhen Third People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Yintao Li, MD

Shandong Cancer Hospital and Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Quanfu Huang, MD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Jiatao Zhang, MD

Guangdong Provincial People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Fang Wu, MD

Second Xiangya Hospital of Central South University

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06930807Not ApplicablePrincipalInvestigator

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Adaptive TreatmentMinimal Residual DiseaseNon-small Cell Lung Cancer
Recruiting

All 1 trials loaded